This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
International Flavors April, May Sales Dip 7% on Coronavirus Woes
by Zacks Equity Research
International Flavors' (IFF) quarter-to-date top-line numbers down on prevalent pressure in certain end-market categories across few countries due to the coronavirus pandemic.
Top 3 Momentum Anomaly Stocks to Consider on Investor Optimism
by Zacks Equity Research
These frontrunners are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.
Clorox (CLX) Appears Promising: What's Driving the Stock?
by Zacks Equity Research
Clorox (CLX) is gaining from a spike in demand for disinfectants as well as the IGNITE strategy. Encouragingly, management lifts fiscal 2020 view.
3 Investing Facts About Required Minimum Distributions You Need to Know - June 02, 2020
by Zacks Equity Research
Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.
Zacks.com featured highlights include: B&G Foods, Sprouts Farmers Market, The Clorox Company, Gold Fields and BJ???s Wholesale Club
by Zacks Equity Research
Zacks.com featured highlights include: B&G Foods, Sprouts Farmers Market, The Clorox Company, Gold Fields and BJ???s Wholesale Club
Clorox (CLX) Up 10.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Reasons Growth Investors Will Love Clorox (CLX)
by Zacks Equity Research
Clorox (CLX) possesses solid growth attributes, which could help it handily outperform the market.
5 Low-Beta Stocks to Beat Coronavirus Blues
by Nilanjan Banerjee
Creating a portfolio of low-beta stocks is of utmost importance since the securities can not only deliver healthy returns but also provide a shield against market volatility.
Add These 4 GARP Stocks to Your Portfolio for Maximum Returns
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Has The Clorox (CLX) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
The Zacks Analyst Blog Highlights: The Clorox Company, MGP Ingredients, Middlesex Water, Baidu and Alibaba
by Zacks Equity Research
The Zacks Analyst Blog Highlights: The Clorox Company, MGP Ingredients, Middlesex Water, Baidu and Alibaba
Why Clorox (CLX) Stock Might be a Great Pick
by Zacks Equity Research
Clorox (CLX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Renewed US-China Tensions Put 3 Safe Stocks on Top
by Zacks Equity Research
Fresh clashes between the two powerful economies amid the pandemic have triggered investors to turn to safe bets, again.
Company News for May 21, 2020
by Zacks Equity Research
Companies In The News Are: MRNA, FB, CLX, RCL.
Clorox (CLX) Announces a Dividend Hike, Cheers Investors
by Zacks Equity Research
Clorox (CLX) gives investors another reason to cheer by raising its dividend for the 51st consecutive quarter. Its IGNITE strategy and strong demand place it well for further growth.
Top Stock Picks for Week of May 18, 2020
by Panel Of Zacks Experts
Consumer Products & Chips in Focus.
Is Clorox (CLX) Stock Still a Great Buy for the Eventual Coronavirus Recovery?
by Benjamin Rains
Clorox topped our quarterly earnings and revenue estimates on May 1, and the stock has jumped 12% since the end of April. Some investors might think the rally is overdone. But is Clorox still a great buy even near its new highs?
The Zacks Analyst Blog Highlights: NVIDIA, Moderna, Clorox, Campbell Soup and General Mills
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Moderna, Clorox, Campbell Soup and General Mills
Zacks.com featured highlights include: BWX, Clorox, Microsoft and Jack Henry
by Zacks Equity Research
Zacks.com featured highlights include: BWX, Clorox, Microsoft and Jack Henry
Zacks.com featured highlights include: Clorox, Sprouts Farmers, Eli Lilly, Gold Fields and AngloGold
by Zacks Equity Research
Zacks.com featured highlights include: Clorox, Sprouts Farmers, Eli Lilly, Gold Fields and AngloGold
4 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Fight Off the Coronavirus Blues With 5 Low-Beta Stocks
by Nilanjan Banerjee
It is an ideal time to invest in low-beta stocks since they might provide a shield against coronavirus-induced market volatility.
Rebalance Your Portfolio to Counter Dilemma Over Recovery
by Nalak Das
At this stage, a combination of aggressive and defensive stocks after filtering with proper selection criteria will be prudent for one's portfolio.
3 Reasons Why Clorox (CLX) Is a Great Growth Stock
by Zacks Equity Research
Clorox (CLX) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights: Wayfair, Chegg, Moderna, Quidel and Clorox
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Wayfair, Chegg, Moderna, Quidel and Clorox